Molecular Therapeutic Targets in Inflammation: Cyclooxygenase and NF-&kgr;B

Publisher： Bentham Science Publishers

E-ISSN： 1875-5933|3|3|317-324

ISSN： 1568-010X

Source： Current Drug Targets. Inflammation & Allergy, Vol.3, Iss.3, 2004-01, pp. : 317-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Naturally Occurring NF-&kgr;B Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 945-951

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr;B in Type 1 Diabetes

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 3, 2011-06 ,pp. : 208-217

Bentham Science Publishers

Access to resources Recommend Favorite

Damnacanthal-Induced Anti-Inflammation is Associated with Inhibition of NF-&kgr;B Activity

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 6, 2011-12 ,pp. : 455-463

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of NF-&kgr;B and Proteasome Activity in Tumors: Can We Improve the Therapeutic Potential of Topoisomerase I and Topoisomerase II Poisons

By  

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1945-1958

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr; B and Rheumatic Diseases

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 359-372

Bentham Science Publishers

Access to resources Recommend Favorite